Lancashire and South Cumbria
Formulary
4 Central nervous system
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents:
mlcsu.lscformulary@nhs.net
.
For more information about the formulary development process, please see:
https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
04-09-03 Drugs used in essential tremor, chorea, tics, and related disorders
Primidone
Formulary
See section 4.8.1
Propranolol
Formulary
See section 2.4
Riluzole
Rilutek
®
Formulary
Tablets 50mg
Suspension 5mg/1ml
Consultant neurologist initiation only
LSCMMG: Shared care guideline
NICE TA20: Guidance on the use of riluzole (Rilutek) for the treatment of motor neurone disease
Tetrabenazine
Xenazine
®
25
Formulary
Tablets 25mg
Links
LSCMMG: Shared care guideline
MHRA safety update regarding toxin spread
NICE NG71: Parkinson’s disease in adults
NICE TA20: Guidance on the use of riluzole (Rilutek) for the treatment of motor neurone disease
NICE TA20: Motor neurone disease - riluzole
Shard Care Guideline - Riluzole
Key
Full Site